Anika Therapeutics (NASDAQ:ANIK – Get Free Report)‘s stock had its “outperform” rating reaffirmed by stock analysts at Barrington Research in a report issued on Tuesday,Benzinga reports. Anika Therapeutics Stock Down 0.7%NASDAQ ANIK traded down $0.07 during trading hours on Tuesday, hitting $9.27. Anika Therapeutics has a twelve month low of $7.87 and a twelve month high of $25.65. Get Anika Therapeutics alerts:Institutional Trading of Anika TherapeuticsHedge funds and other institutional investors have recently modified their holdings of the business. Further ReadingReceive News & Ratings for Anika Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anika Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.